The S&P/ASX 200 Index (ASX: XJO) is in the red in Tuesday morning trade, down another 0.54%. If the index keeps tumbling, it'll mark six straight days of declines.
The Australian share market has seen widespread selling across most sectors and weak investor sentiment. The ASX 200 is also reacting to a mixed start in US sharemarkets this week.
The softer market has also seen some ASX 200 shares fall to fresh 52-week lows.
Here are four of them.
Image source: Getty Images
Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH)
Fisher & Paykel shares are down another 0.24% this morning to a new 52-week low of $29.18 a piece. The slump means the respiratory designer and manufacturer's share price is now 10% lower year to date and 9% lower than this time last year. There hasn't been any price-sensitive news out of the company recently to explain the decline, so it's most likely the result of a continued sector-wide sell-off of ASX healthcare shares. TradingView data suggests brokers are still bullish for the ASX 200 company's shares, with the majority holding a buy or strong buy rating on the stock. Brokers tip an average 20% upside to $34.86 over the next 12 months.
Ansell Ltd (ASX: ANN)
Ansell is another ASX 200 healthcare company that makes gloves and other personal protection equipment. Its shares have also been caught up in the widespread ASX healthcare sell-off. At the time of writing, Ansell shares are down 1.06% to $26.24 a piece, marking a 22-month low. Again, brokers are bullish about the outlook for the ASX 200 company's shares. Out of 12 analysts, seven have a hold rating and 5 rate the shares a buy or strong buy. Brokers tip an average 34% upside to $35.18 over the next 12 months. Some think the shares can rocket even further. The maximum $40.45 target price implies a potential 54% upside at the time of writing.
Harvey Norman Holdings Ltd (ASX: HVN)
Harvey Norman shares have hit a fresh 52-week low of $4.47 in Tuesday morning trade. The share price has now crashed 36% for the year to date after the sell-off accelerated in late February. The ASX 200 retail giant has faced strong headwinds over the past year on the back of renewed concerns about rising inflation and how it could impact consumer spending. Tighter household budgets mean Australians are spending less on discretionary items this year. At the same time, after a strong rally in mid-late 2025, it looks like investors quickly took their profits off the table in early 2026. TradingView data shows that analysts are relatively divided about the outlook for the shares, with several neutral ratings, but they mostly agree that the shares are now trading below fair value. The average target price on the ASX 200 retail shares is $5.76, which implies another 29% upside at the time of writing.
Metcash Ltd (ASX: MTS)
Metcash shares have tumbled another 1.42% in morning trade to a new 52-week low of $2.78 a piece. It also represents the lowest point the shares have fallen to in nearly six years. The IGA network owner's shares have come under pressure following an underwhelming FY26 half-year result in December last year. It continues to face headwinds amid a tough retail environment and dwindling demand in its tobacco and liquor businesses. Analysts are mostly neutral on the outlook for the shares, but they do all agree that there will be some level of upside ahead. The average target price of $3.44 implies a potential 23% upside over the next 12 months, at the time of writing.
